Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Invitrogen has received the FDA clearance for its DynaChip antibody analysis system, an automated chip-based system for human leukocyte antigen antibody detection and identification.
Subscribe to our email newsletter
Invitrogen’s DynaChip antibody analysis system is said to provide fully integrated instrumentation, reagents and software for automated detection and identification of human leukocyte antigen antibodies.
Kip Miller, senior vice president of biodiscovery at Invitrogen, said: “We’re very pleased to have received this FDA approval, which validates the accuracy of DynaChip data and demonstrates Invitrogen’s commitment to providing clinicians with accurate and more efficient solutions.”